HiperScan GmbH

HiperScan GmbH develops advanced analytical solutions utilizing Near-Infrared (NIR) spectroscopy technology, focusing on quality control and compliance for raw materials in various industries. Founded in 2006 and headquartered in Dresden, Germany, HiperScan GmbH specializes in analytical solutions leveraging NIR spectroscopy. The company has undergone no significant pivots and operates independently. Founded by Hubert Lakner, HiperScan has completed 2 funding deals, with the latest round occurring on September 23, 2013, which raised EUR 0.

45 million led by HCS Beteiligungsgesellschaft, along with investors CFH Management and High-Tech Gründerfonds. The total amount raised by the company is EUR 0. 45 million, with a current valuation of EUR 9. 16 million.

HiperScan GmbH specializes in innovative analytical solutions utilizing Near-Infrared (NIR) spectroscopy technology. Their core product offerings include the Apo-Ident system, tailored for pharmacies to enable rapid, cost-effective, and secure verification of raw materials for compliance and quality control in pharmaceutical preparations. Additionally, the Finder series, including the Finder SD and Finder SD Rotator, provides flexible, real-time analysis capabilities for various substances across sectors such as food, agriculture, and chemical manufacturing. Their products are marketed primarily in Europe, particularly Germany, and extend to international markets within the pharmaceutical, food, and chemical industries.

HiperScan GmbH generates revenue through direct sales of their NIR analytical devices and systems, often accompanied by a validated substance database for efficient identity verification processes. Operating on a B2B model, they service pharmacies, laboratories, and various industrial sectors. Clients purchase equipment such as the Apo-Ident and Finder models, typically involving upfront payments with potential ongoing service agreements or maintenance contracts. The firm emphasizes delivering high-value, reliable technologies to foster long-term partnerships with clients requiring consistent quality assurance in their operations.

In September 2013, HiperScan GmbH raised EUR 0. 45 million to support its growth initiatives. The funding will be utilized to enhance their product offerings and explore new market opportunities. The company aims to expand its presence in international markets, focusing on the pharmaceutical and food sectors, although specific regions and timelines for expansion are not detailed.

Upcoming products are in the design phase, with an emphasis on enhancing analytical capabilities and meeting industry demands.